Erowid Monthly
If you'd like to receive an email when a new Erowid Monthly is available, visit our sign-up page.

Erowid is seeking experience reports written by women. If you or a woman you know have written about your experiences with psychoactive plants or chemicals, please consider submitting one or more reports to Erowid. We want to make sure that our collection appropriately represents differences between the experiences of men and women.

Submit an Experience Report
In History . . .
In The Flesh: Seventy-five years ago (Jul 18, 1937), celebrated American author and psychoactive drug enthusiast Hunter S. Thompson was born.

In The News: Forty-three years ago (1969), hippies were pictured on a LIFE magazine cover that announced: "The Youth Communes--New Way of Living Confronts the U.S.".

In The Law: Ten years ago (2002), the DEA declared its intent to emergency schedule 2C-T-7, BZP, and TFMPP. Seven years ago (2005), a British ban on psilocybin-containing mushrooms took effect.
Wicked Plants: The Exhibit
(through September 12, 2012) at North Carolina Arboretum, Asheville
Latest Additions
An examination of published and unpublished accounts of deaths linked to the recreational use of this dissociative anesthetic reveals incidents in four categories: pharmacological fatalities, behavioral fatalities, suicides, and homicides.
The Johns Hopkins research into the effects of psilocybin on normal adults hints at support for the idea that a dose around 20 mg/70 kg can facilitate a meaningful and/or mystical-type experience, and that preceding higher doses with lower doses could be beneficial.
This new timeline showing the history of conferences and events related to psychoactives, with an emphasis on psychedelics, provides a unique chronological view of the development of the science and culture of this field, from the 1950s to the present.
The next time you hear someone bemoaning the scourge of recreational drug users, ask them if what they're talking about isn't actually irresponsible drug use. Because recreation, after all, is really a rather lovely word.
Crew Notes
The Adult Autism and MDMA/Ecstasy Study (until Jul 31, 2012)

For her PhD dissertation, Alicia Danforth is collecting surveys and personal accounts from autistic/Aspergian adults (age 21+) who've had experiences with MDMA (ecstasy). Those who fit the criteria are encouraged to visit her web site before the end of July.

Survey: Ecstasy Craving & Ecstasy Use (until Sep 15, 2012)

Graduate student Alan Davis is exploring the subjective experience of craving for ecstasy and other aspects of people's ecstasy experiences. To participate in this survey, you must be 18-65 years old, have used ecstasy at least 30 times over your lifetime, and at least every other week for the past six months.
From the Vaults
Though kava's primary use throughout Oceania is as a social, mood-enhancing beverage, the plant is also part of the native pharmacopoeia of that region, and is used medicinally for a wide range of conditions.
More New Content
  1. 4-Fluoromethcathinone (4-FMC) Vault
    Though among the earliest substituted cathinones to be released onto the "legal high" market, flephedrone has not been one of the more popular, and like many, reported experiences with it vary widely.
  2. Anthropology that Flourishes Outside the Academy
    In this interview, which originally appeared in Portuguese, anthropologists Bia Labate and Anthony Richard Henman discuss the history and effects of San Pedro cactus.
  3. World Drug Report - 2012
    The annual report by the United Nations Office on Drugs and Crime on trends in illicit drug markets around the world.
Erowid is frequently mentioned in articles and books. These mentions may be reviews, recommendations or the use of Erowid as a reference.
  • Neuropharmacology
    "What should we do about student use of cognitive enhancers?", Jun 2012
    Describes as "[hosting] drug-related information and the most comprehensive list of user-generated experience accounts."
  • IACAPAP Textbook of Child and Adolescent Mental Health
    Chapter G.3, "Other substance use", Jun 2012
    Refers to as "a useful website with information about everything to do with drugs".
Ecstasy Data
EcstasyData is a project of Erowid Center that conducts laboratory testing of street Ecstasy tablets and publishes these and other test results online.
Donate Or Become A Member
If you find Erowid a useful resource and are interested in supporting its future development, please consider donating or becoming a member. Donations to Erowid Center are tax-deductible in the United States.
List Subscription Information
  • To UNSUBSCRIBE - send an empty email to:
  • To SUBSCRIBE - send an empty email to: